Ilena Rosenthal & The Humantics Foundation:
www.BreastImplantAwareness.org/

http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=Retrieve&dopt=...

1: Regul Toxicol Pharmacol. 2007 Apr 14; [Epub ahead of print]
    Evaluating emerging issues in epidemiology.
    Collins JJ, Bukowski JA, Weed DL, Brent RL, Klein P,
Boerstoel-Streefland M, Sprafka JM, Williams AL, Holsapple MP.

    The Dow Chemical Co., Midland, MI 48674, USA.

    Industry and government institutions need a credible approach for
evaluating and responding to emerging public health issues.
Representatives of industry, government, and academia met under the
auspices of the International Life Sciences Institute's Health and
Environmental Sciences Institute (HESI) to develop successful
strategies for dealing with emerging issues based on historical case
studies. The case studies chosen for evaluation were (1) tampon use
and toxic shock syndrome; (2) hazardous waste and childhood cancer
risk in Toms River, New Jersey; (3) fenfluramine and phentermine use
and valvular heart disease; (4) silicone breast implants and cancer
and auto-immune disease; and (5) progestational drugs and birth
defects. We identified eight lessons from these case studies.
Foremost, we recommend that public and private institutions not defer
action until an issue is scientifically resolved and stress that
cooperation among issue stakeholders is critical for effective issue
resolution. We suggest establishing a research program as an effective
way to assure that good science is included in resolution of the
issue. We further recommend frequent and timely communication with all
stakeholders, and the development of research approaches to fill gaps
when the scientific data on an issue are limited.

    PMID: 17543434 [PubMed - as supplied by publisher]

    Related Links

        * Lessons from the history of tobacco harm reduction: The
National Cancer Institute's Smoking and Health Program and the "less
hazardous cigarette". [Nicotine Tob Res. 2005]
        * Risk management frameworks for human health and
environmental risks. [J Toxicol Environ Health B Crit Rev. 2003]
        * Dose-dependent transitions in mechanisms of toxicity.
[Toxicol Appl Pharmacol. 2004]
        * American Society of Clinical Oncology policy statement:
oversight of clinical research. [J Clin Oncol. 2003]
        * Reducing obesity and related chronic disease risk in
children and youth: a synthesis of evidence with 'best practice'
recommendations. [Obes Rev. 2006]

    See all Related Articles...

 Display Show

Write to the Help Desk
NCBI | NLM | NIH
Department of Health & Human Services
Privacy Statement | Freedom of Information Act | Disclaimer